Anika Therapeutics CEO Charles Sherwood's 2018 pay rises 18% to $5M
Anika Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Anika Therapeutics reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, six executives at Anika Therapeutics received on average a compensation package of $1.8M, a 14% increase compared to previous year.
Average pay of disclosed executives at Anika Therapeutics
Charles H. Sherwood, Chief Executive Officer, received $5M in total, which increased by 18% compared to 2017. 70% of Sherwood's compensation, or $3.5M, was in stock awards. Sherwood also received $148K in salary and $1.3M in other compensation.
Joseph G. Darling, Chief Executive Officer, received a compensation package of $2.2M, which increased by 22% compared to previous year. 34% of the compensation package, or $728K, was in option awards.
Sylvia Cheung, Chief Financial Officer, earned $1.3M in 2018, a 1% increase compared to previous year.
Edward Ahn, Chief Technology and Strategy Officer, received $914K in 2018, which decreases by 16% compared to 2017.
Richard Hague, Chief Commercial Officer, earned $827K in 2018, a 22% decrease compared to previous year.
Thomas Finnerty, Chief Human Resources Officer, received $759K in 2018, which increases by 6% compared to 2017.
Related executives
Joseph Darling
Anika Therapeutics
Chief Executive Officer
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
Edward Ahn
Anika Therapeutics
Chief Technology and Strategy Officer
Thomas Finnerty
Anika Therapeutics
EVP, Human Resources
Richard Hague
Anika Therapeutics
Chief Commercial Officer
Charles Sherwood
Anika Therapeutics
Chief Executive Officer
You may also like
Source: SEC filing on April 25, 2019.